INCYTE CORP 4
0002083591-26-000005
View on SEC EDGAREVP of Human Resources Ramitpal K. Basi received RSUs, performance shares, and stock options of Incyte Corp. as part of an equity compensation grant rather than buying or selling shares in the market.
On July 16, 2026, Ramitpal K. Basi, EVP of Human Resources at Incyte Corp., received a package of equity compensation awards consisting of 4,991 restricted stock units (RSUs) that vest 25% annually over four years, 12,479 performance share units that can pay out up to 200% of the target shares based on relative total shareholder return over a three‑year period ending July 16, 2029, and stock options for 21,548 shares at an exercise price of $116.65 that vest 25% after one year with the remaining 75% vesting monthly over the following three years. These grants increased his derivative and non‑derivative beneficial ownership to a total of 11,497 time‑based RSUs outstanding (including prior awards), 12,479 performance shares, and 21,548 stock options, all held directly as part of ongoing executive compensation rather than open‑market trading. Using the option exercise price as a proxy for the company’s share price, the notional grant-date value of the RSUs and performance shares is roughly in the mid‑seven‑figure range and the options represent an additional leveraged upside component, but no shares were purchased or sold for cash in the market in connection with this Form 4.
Filing Facts
- CIK
- 879169
- Ticker
- INCY
- Form
- 4
- Source Type
- fda
- Accession
- 0002083591-26-000005
- Alert Tier
- 6